Financhill
Sell
22

EOLS Quote, Financials, Valuation and Earnings

Last price:
$5.67
Seasonality move :
47.28%
Day range:
$5.13 - $5.81
52-week range:
$5.13 - $17.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.27x
P/B ratio:
116.53x
Volume:
3.1M
Avg. volume:
988K
1-year change:
-44.66%
Market cap:
$366.2M
Revenue:
$266.3M
EPS (TTM):
-$0.91

Analysts' Opinion

  • Consensus Rating
    Evolus, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $18.50, Evolus, Inc. has an estimated upside of 227.43% from its current price of $5.65.
  • Price Target Downside
    According to analysts, the lowest downside price target is $14.00 representing -147.79% downside risk from its current price of $5.65.

Fair Value

  • According to the consensus of 6 analysts, Evolus, Inc. has 227.43% upside to fair value with a price target of $18.50 per share.

EOLS vs. S&P 500

  • Over the past 5 trading days, Evolus, Inc. has underperformed the S&P 500 by -17.22% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Evolus, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Evolus, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Evolus, Inc. reported revenues of $69M.

Earnings Growth

  • Evolus, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evolus, Inc. reported earnings per share of -$0.24.
Enterprise value:
477.6M
EV / Invested capital:
--
Price / LTM sales:
1.27x
EV / EBIT:
--
EV / Revenue:
1.67x
PEG ratio (5yr expected):
-1.02x
EV / Free cash flow:
-8.24x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$183.9M
Return On Assets:
-26.07%
Net Income Margin (TTM):
-20.49%
Return On Equity:
-5666.82%
Return On Invested Capital:
-44.55%
Operating Margin:
-14.74%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $184.7M $248.3M $285.8M $61.1M $69M
Gross Profit $124.3M $168.4M $183.9M $41.8M $44.7M
Operating Income -$39.9M -$31.6M -$41M -$13M -$10.2M
EBITDA -$34.3M -$25.8M -$33.2M -$11.8M -$7.9M
Diluted EPS -$1.11 -$0.91 -$0.91 -$0.30 -$0.24
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $138.3M $115.9M $92M $150.4M $134.9M
Total Assets $215.2M $192.7M $168M $229.6M $219M
Current Liabilities $71.3M $51.3M $48.5M $60.8M $66.7M
Total Liabilities $117.8M $163.5M $187.3M $223.7M $247.8M
Total Equity $97.4M $29.2M -$19.4M $5.9M -$28.8M
Total Debt $22.4M $73.2M $100.1M $128.3M $152.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$43.6M -$22M -$50.3M -$5.7M -$14.7M
Cash From Investing -$2.7M -$3.8M -$7.6M -$1.4M -$2.2M
Cash From Financing $19.6M $72.2M $15.9M -$1.4M -$1.8M
Free Cash Flow -$46.3M -$25.8M -$57.9M -$7.1M -$16.8M
EOLS
Sector
Market Cap
$366.2M
$28.1M
Price % of 52-Week High
33%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-2.07%
-1.59%
1-Year Price Total Return
-44.66%
-17.31%
Beta (5-Year)
0.916
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $6.12
200-day SMA
Sell
Level $8.32
Bollinger Bands (100)
Sell
Level 6.3 - 7.28
Chaikin Money Flow
Sell
Level -89M
20-day SMA
Sell
Level $6.68
Relative Strength Index (RSI14)
Sell
Level 28.36
ADX Line
Sell
Level 20.68
Williams %R
Neutral
Level -75.4717
50-day SMA
Sell
Level $6.80
MACD (12, 26)
Sell
Level -0.30
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 3.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.6014)
Sell
CA Score (Annual)
Level (-3.012)
Buy
Beneish M-Score (Annual)
Level (-2.6801)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.652)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Stock Forecast FAQ

In the current month, EOLS has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The EOLS average analyst price target in the past 3 months is $18.50.

  • Where Will Evolus, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Evolus, Inc. share price will rise to $18.50 per share over the next 12 months.

  • What Do Analysts Say About Evolus, Inc.?

    Analysts are divided on their view about Evolus, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evolus, Inc. is a Sell and believe this share price will drop from its current level to $14.00.

  • What Is Evolus, Inc.'s Price Target?

    The price target for Evolus, Inc. over the next 1-year time period is forecast to be $18.50 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is EOLS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Evolus, Inc. is a Buy. 5 of 6 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of EOLS?

    You can purchase shares of Evolus, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evolus, Inc. shares.

  • What Is The Evolus, Inc. Share Price Today?

    Evolus, Inc. was last trading at $5.67 per share. This represents the most recent stock quote for Evolus, Inc.. Yesterday, Evolus, Inc. closed at $5.65 per share.

  • How To Buy Evolus, Inc. Stock Online?

    In order to purchase Evolus, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock